Author

Emily Scheib

University of Manchester

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:biophysical modeling· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Allen C. GaoiD· 1 shared Anthony TigheiD· 1 shared Beat C. BornhauseriD· 1 shared Brandon Q. MercadoiD· 1 shared Christopher R. VakociD· 1 shared Debanjan BhattacharjeeiD· 1 shared Erin L. SausvilleiD· 1 shared Jason M. SheltzeriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Allen C. GaoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A clinical-stage oncology compound selectively targets drug-resistant cancers

Kaitlin Long, Debanjan Bhattacharjee, Samuel H. Newman-Stonebraker, Simon Suhr, Brandon Q. Mercado, Emily Scheib, Anthony Tighe, Luciano Romero, Sarah L. Thompson, Erin L. Sausville, Kristen M. John, Linda Julian, Sanat Mishra, Olaf Klingbeil, Punya Gupta, , Jason M. Sheltzer

This study reveals that PAC-1, a clinical-stage oncology compound, targets drug-resistant cancers by disrupting iron homeostasis and exploiting MDR1 expression to induce iron depletion.

bioRxiv · Nov 26, 2025 · PreprintCancer Biology